{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:38:16Z","timestamp":1762954696669,"version":"3.33.0"},"reference-count":72,"publisher":"Oxford University Press (OUP)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,7,18]]},"DOI":"10.1093\/jnci\/djm044","type":"journal-article","created":{"date-parts":[[2007,7,11]],"date-time":"2007-07-11T02:18:37Z","timestamp":1184120317000},"page":"1107-1119","source":"Crossref","is-referenced-by-count":79,"title":["Histone Deacetylase 1 Gene Expression and Sensitization of Multidrug-Resistant Neuroblastoma Cell Lines to Cytotoxic Agents by Depsipeptide"],"prefix":"10.1093","volume":"99","author":[{"given":"Nino","family":"Keshelava","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elai","family":"Davicioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zesheng","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyun","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Sposto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy J.","family":"Triche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Patrick","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2007,7,18]]},"reference":[{"key":"key\n\t\t\t\t20170715053820_bib1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM199102143240706","article-title":"Common solid tumors of childhood","volume":"324","author":"Crist","year":"1991","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170715053820_bib2","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1056\/NEJM199910143411601","article-title":"Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group","volume":"341","author":"Matthay","year":"1999","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170715053820_bib3","first-page":"5396","article-title":"Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy","volume":"58","author":"Keshelava","year":"1998","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170715053820_bib4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/1096-911X(20001201)35:6<563::AID-MPO15>3.0.CO;2-J","article-title":"p53 mutations and loss of p53 function confer multidrug resistance in neuroblastoma","volume":"35","author":"Keshelava","year":"2000","journal-title":"Med Pediatr Oncol"},{"key":"key\n\t\t\t\t20170715053820_bib5","first-page":"6185","article-title":"Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines","volume":"61","author":"Keshelava","year":"2001","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170715053820_bib6","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/ijc.20171","article-title":"Profiling and functional annotation of mRNA gene expression in pediatric rhabdomyosarcoma and Ewing's sarcoma","volume":"110","author":"Baer","year":"2004","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20170715053820_bib7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lab.2004.04.005","article-title":"Characterization of sarcomas by means of gene expression","volume":"144","author":"Skubitz","year":"2004","journal-title":"J Lab Clin Med"},{"key":"key\n\t\t\t\t20170715053820_bib8","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/jnci\/djj330","article-title":"Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification","volume":"98","author":"Asgharzadeh","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20170715053820_bib9","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1182\/blood-2004-03-1154","article-title":"Gene expression profiling of pediatric acute myelogenous leukemia","volume":"104","author":"Ross","year":"2004","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170715053820_bib10","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1023\/A:1020913123054","article-title":"cDNA microarray analysis of changes in gene expression induced by neuronal hypoxia in vitro","volume":"27","author":"Jin","year":"2002","journal-title":"Neurochem Res"},{"key":"key\n\t\t\t\t20170715053820_bib11","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s00109-004-0527-2","article-title":"Global gene expression in human myocardium-oligonucleotide microarray analysis of regional diversity and transcriptional regulation in heart failure","volume":"82","author":"Kaab","year":"2004","journal-title":"J Mol Med"},{"key":"key\n\t\t\t\t20170715053820_bib12","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1158\/1078-0432.CCR-1025-3","article-title":"Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays","volume":"10","author":"Kang","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20170715053820_bib13","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1182\/blood-2004-05-1693","article-title":"A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia","volume":"105","author":"Byrd","year":"2005","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170715053820_bib14","first-page":"718","article-title":"Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms","volume":"8","author":"Sandor","year":"2002","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20170715053820_bib15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1359-4117.2002.01039.x","article-title":"A phase I trial of depsipeptide (FR901228) in patients with advanced cancer","volume":"2","author":"Marshall","year":"2002","journal-title":"J Exp Ther Oncol"},{"key":"key\n\t\t\t\t20170715053820_bib16","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1200\/jco.2005.23.16_suppl.4669","article-title":"A phase II study of depsipeptide (dep) in patients (pts) with metastatic renal cell cancer (RCC). ASCO Annual Meeting Proceedings (Post-Meeting Edition)","volume":"23","author":"Stadler","year":"2005","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170715053820_bib17","first-page":"6108","article-title":"MS-27-275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors","volume":"62","author":"Jaboin","year":"2002","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170715053820_bib18","doi-asserted-by":"crossref","first-page":"11295","DOI":"10.1073\/pnas.94.21.11295","article-title":"A histone deacetylase inhibitor potentiates retinoid receptor action in embryonal carcinoma cells","volume":"94","author":"Minucci","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170715053820_bib19","first-page":"65","article-title":"Effects of sodium butyrate, a new pharmacological agent, on cells in culture","volume":"42","author":"Kruh","year":"1982","journal-title":"Mol Cell Biochem"},{"key":"key\n\t\t\t\t20170715053820_bib20","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1128\/MCB.25.5.1608-1619.2005","article-title":"Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas","volume":"25","author":"Duan","year":"2005","journal-title":"Mol Cell Biol"},{"key":"key\n\t\t\t\t20170715053820_bib21","first-page":"3591","article-title":"The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid","volume":"61","author":"Coffey","year":"2001","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170715053820_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/PL00006736","article-title":"Cross-resistance of topoisomerase I and II inhibitors in neuroblastoma cell lines","volume":"45","author":"Keshelava","year":"2000","journal-title":"Cancer Chemother Pharmacol"},{"key":"key\n\t\t\t\t20170715053820_bib23","first-page":"3551","article-title":"Pharmacokinetics of vincristine sulfate in adult cancer patients","volume":"41","author":"Sethi","year":"1981","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170715053820_bib24","doi-asserted-by":"crossref","first-page":"8012","DOI":"10.1073\/pnas.121616198","article-title":"Short tandem repeat profiling provides an international reference standard for human cell lines","volume":"98","author":"Masters","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170715053820_bib25","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1158\/1535-7163.MCT-04-0331","article-title":"A novel cytotoxicity assay based on fluorescence digital image microscopy that provides over 4 logs of dynamic range in 96-well plates","volume":"6","author":"Frgala","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"key\n\t\t\t\t20170715053820_bib26","first-page":"139","article-title":"DIMSCAN: a microcomputer fluorescence-based cytotoxicity assay for preclinical testing of combination chemotherapy","volume":"110","author":"Keshelava","year":"2005","journal-title":"Methods Mol Med"},{"key":"key\n\t\t\t\t20170715053820_bib27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bbrc.2003.09.043","article-title":"Role of class I and class II histone deacetylases in carcinoma cells using siRNA","volume":"310","author":"Glaser","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t20170715053820_bib28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Ser B"},{"key":"key\n\t\t\t\t20170715053820_bib29","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1158\/0008-5472.CAN-04-1985","article-title":"Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung","volume":"65","author":"Talbot","year":"2005","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170715053820_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships\u2014the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"key\n\t\t\t\t20170715053820_bib31","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol Rev"},{"key":"key\n\t\t\t\t20170715053820_bib32","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/9511","article-title":"Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo","volume":"5","author":"Sethi","year":"1999","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170715053820_bib33","first-page":"2446","article-title":"Effect of overexpression of the small heat shock protein HSP27 on the heat and drug sensitivities of human testis tumor cells","volume":"56","author":"Richards","year":"1996","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170715053820_bib34","doi-asserted-by":"crossref","first-page":"7706","DOI":"10.1158\/0008-5472.CAN-03-3897","article-title":"Overexpression of histone deacetylase 1 confers resistance to sodium butyrate-mediated apoptosis in melanoma cells through a p53-mediated pathway","volume":"64","author":"Bandyopadhyay","year":"2004","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170715053820_bib35","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/1479-7364-1-6-460","article-title":"Analysis of the glutathione S-transferase (GST) gene family","volume":"1","author":"Nebert","year":"2004","journal-title":"Hum Genomics"},{"key":"key\n\t\t\t\t20170715053820_bib36","first-page":"1273","article-title":"Glutathione (GSH) and RNA expression of GSH synthetic and utilization enzymes are increased in drug-resistant neuroblastoma cell lines","volume":"44","author":"Yang","year":"2003","journal-title":"Proc Am Assoc Cancer Res"},{"key":"key\n\t\t\t\t20170715053820_bib37","doi-asserted-by":"crossref","first-page":"13581","DOI":"10.1074\/jbc.M601580200","article-title":"Mechanisms of the copper-dependent turnover of the copper chaperone for superoxide dismutase","volume":"281","author":"Caruano-Yzermans","year":"2006","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170715053820_bib38","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1128\/MCB.00266-06","article-title":"p18 Ink4c and Pten constrain a positive regulatory loop between cell growth and cell cycle control","volume":"26","author":"Bai","year":"2006","journal-title":"Mol Cell Biol"},{"key":"key\n\t\t\t\t20170715053820_bib39","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"key\n\t\t\t\t20170715053820_bib40","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1200\/JCO.2006.06.4964","article-title":"Phase I study of depsipeptide in pediatric patients with refractory solid tumors: a Children's Oncology Group report","volume":"24","author":"Fouladi","year":"2006","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170715053820_bib41","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1158\/0008-5472.CAN-05-2623","article-title":"Increased frequency of aberrations in the p53\/MDM2\/p14(ARF) pathway in neuroblastoma cell lines established at relapse","volume":"66","author":"Carr","year":"2006","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170715053820_bib42","doi-asserted-by":"crossref","first-page":"20536","DOI":"10.1074\/jbc.M100400200","article-title":"Overexpression of TAP\/p15 heterodimers bypasses nuclear retention and stimulates nuclear mRNA export","volume":"276","author":"Braun","year":"2001","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170715053820_bib43","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1128\/MCB.25.1.206-219.2005","article-title":"Core promoter binding by histone-like TAF complexes","volume":"25","author":"Shao","year":"2005","journal-title":"Mol Cell Biol"},{"key":"key\n\t\t\t\t20170715053820_bib44","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00043426-200111000-00007","article-title":"Buthionine sulfoximine and myeloablative concentrations of melphalan overcome resistance in a melphalan-resistant neuroblastoma cell line","volume":"23","author":"Anderson","year":"2001","journal-title":"J Pediatr Hematol Oncol"},{"key":"key\n\t\t\t\t20170715053820_bib45","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/07357900600814979","article-title":"Histone deacetylase inhibitors, chemotherapy, cancer","volume":"24","author":"Fouladi","year":"2006","journal-title":"Cancer Invest"},{"key":"key\n\t\t\t\t20170715053820_bib46","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.bjc.6602309","article-title":"Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells","volume":"92","author":"Stockhausen","year":"2005","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t20170715053820_bib47","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.1158\/1078-0432.CCR-04-0395","article-title":"Favorable neuroblastoma genes and molecular therapeutics of neuroblastoma","volume":"10","author":"Tang","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20170715053820_bib48","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1073\/pnas.0408351102","article-title":"Ku70 acetylation mediates neuroblastoma cell death induced by histone deacetylase inhibitors","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170715053820_bib49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jmb.2004.02.006","article-title":"Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis","volume":"338","author":"Gregoretti","year":"2004","journal-title":"J Mol Biol"},{"key":"key\n\t\t\t\t20170715053820_bib50","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1749-6632.2003.tb05964.x","article-title":"Histone deacetylases: unique players in shaping the epigenetic histone code","volume":"983","author":"Thiagalingam","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"key\n\t\t\t\t20170715053820_bib51","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/jnci\/92.15.1210","article-title":"Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells","volume":"92","author":"Marks","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20170715053820_bib52","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1182\/blood.V98.9.2865","article-title":"Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report","volume":"98","author":"Piekarz","year":"2001","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170715053820_bib53","first-page":"3028","article-title":"Update on the phase II trial and correlative studies of depsipeptide in patients with cutaneous T-cell lymphoma and relapsed peripheral T-cell lymphoma","volume":"22","author":"Piekarz","year":"2004","journal-title":"ASCO Annual Meeting Proceedings (Post-Meeting Edition). J Clin Oncol"},{"key":"key\n\t\t\t\t20170715053820_bib54","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1200\/JCO.2005.14.167","article-title":"Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer","volume":"23","author":"Kelly","year":"2005","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170715053820_bib55","first-page":"3578","article-title":"Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously","volume":"9","author":"Kelly","year":"2003","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20170715053820_bib56","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1200\/JCO.2005.02.188","article-title":"Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma","volume":"23","author":"Ryan","year":"2005","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170715053820_bib57","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00277-005-0026-8","article-title":"Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia","volume":"84","author":"Kuendgen","year":"2005","journal-title":"Ann Hematol"},{"key":"key\n\t\t\t\t20170715053820_bib58","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1158\/1078-0432.CCR-05-1225","article-title":"Evaluation of the antitumor efficacy, pharmacokinetics, and pharmacodynamics of the histone deacetylase inhibitor depsipeptide in childhood cancer models in vivo","volume":"12","author":"Graham","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20170715053820_bib59","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jcb.20045","article-title":"Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid","volume":"92","author":"Marchion","year":"2004","journal-title":"J Cell Biochem"},{"key":"key\n\t\t\t\t20170715053820_bib60","first-page":"121","article-title":"The histone deacetylase inhibitor sodium butyrate induces DNA topoisomerase II alpha expression and confers hypersensitivity to etoposide in human leukemic cell lines","volume":"1","author":"Kurz","year":"2001","journal-title":"Mol Cancer Ther"},{"key":"key\n\t\t\t\t20170715053820_bib61","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0378-1119(00)00040-8","article-title":"Cell-cycle regulation of the DNA topoisomerase II alpha promoter is mediated by proximal CCAAT boxes: possible involvement of acetylation","volume":"245","author":"Adachi","year":"2000","journal-title":"Gene"},{"key":"key\n\t\t\t\t20170715053820_bib62","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1365-2141.2004.04882.x","article-title":"Analysis of histone deacetylase inhibitor, depsipeptide (FR901228), effect on multiple myeloma","volume":"125","author":"Khan","year":"2004","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20170715053820_bib63","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0014-4827(85)90180-6","article-title":"Effects of X-irradiation and sodium butyrate on cell-cycle traverse on normal and radiosensitive lymphoblastoid cells","volume":"160","author":"Smith","year":"1985","journal-title":"Exp Cell Res"},{"key":"key\n\t\t\t\t20170715053820_bib64","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1158\/0008-5472.CAN-03-2630","article-title":"Enhanced radiation-induced cell killing and prolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275","volume":"64","author":"Camphausen","year":"2004","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170715053820_bib65","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijrobp.2004.12.088","article-title":"Modulation of radiation response by histone deacetylase inhibition","volume":"62","author":"Chinnaiyan","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key\n\t\t\t\t20170715053820_bib66","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1158\/1535-7163.MCT-04-0304","article-title":"Cell cycle checkpoint signaling involved in histone deacetylase inhibition and radiation-induced cell death","volume":"4","author":"Nome","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"key\n\t\t\t\t20170715053820_bib67","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1124\/jpet.105.083956","article-title":"Chemoresistance to depsipeptide FK228 [(E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithi a-5,8,20,23-tetraazabicyclo[8,7,6]-tricos-16-ene-3,6,9,22-pentanone] is mediated by reversible MDR1 induction in human cancer cell lines","volume":"314","author":"Xiao","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20170715053820_bib68","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1158\/1078-0432.CCR-05-1423","article-title":"Increased MDR1 expression in normal and malignant peripheral blood mononuclear cells obtained from patients receiving depsipeptide (FR901228, FK228, NSC630176)","volume":"12","author":"Robey","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20170715053820_bib69","first-page":"7291","article-title":"Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA","volume":"63","author":"Kim","year":"2003","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170715053820_bib70","doi-asserted-by":"crossref","first-page":"6066","DOI":"10.1158\/1078-0432.CCR-04-0537","article-title":"Enhancement of xenograft tumor radiosensitivity by the histone deacetylase inhibitor MS-275 and correlation with histone hyperacetylation.","volume":"10","author":"Camphausen","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20170715053820_bib71","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1124\/mol.51.6.1024","article-title":"P-glycoprotein substrates and antagonists cluster into two distinct groups","volume":"51","author":"Scala","year":"1997","journal-title":"Mol Pharmacol"},{"key":"key\n\t\t\t\t20170715053820_bib72","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1124\/jpet.104.072033","article-title":"Efflux of depsipeptide FK228 (FR901228, NSC-630176) is mediated by P-glycoprotein and multidrug resistance-associated protein 1","volume":"313","author":"Xiao","year":"2005","journal-title":"J Pharmacol Exp Ther"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/99\/14\/1107\/18614799\/djm044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T05:00:47Z","timestamp":1737262847000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/djm044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,18]]},"references-count":72,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2007,7,18]]},"published-print":{"date-parts":[[2007,7,18]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djm044","relation":{},"ISSN":["1460-2105","0027-8874"],"issn-type":[{"type":"electronic","value":"1460-2105"},{"type":"print","value":"0027-8874"}],"subject":[],"published":{"date-parts":[[2007,7,18]]}}}